Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

BIS range and propofol depth during total IV anesthesia with adjuvants for knee replacement

Official title: A Prospective, Randomized Study to Determine the Appropriate Bispectral Index Range and Propofol Effect-Site Concentration During Total Intravenous Anesthesia Combined With Midazolam, Dexmedetomidine or Esketamine.

Run by China-Japan Friendship Hospital · NCT07736352 · Data updated 2026-11-12

This study tests the right BIS range and propofol level to keep anesthesia deep enough when using propofol with midazolam, dexmedetomidine, or esketamine in knee replacement patients.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorChina-Japan Friendship Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedJuly 30, 2026
Main results expectedJanuary 31, 2027
Study endsJuly 31, 2027
Registry record updatedOctober 28, 2026
Trial IDNCT07736352 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-65 years with ASA I-II status undergoing elective unilateral total knee replacement, able to consent and comply with procedures.

Probably not a fit

Patients with neurological conditions, cognitive impairment, significant cardiovascular issues, or allergy to intravenous anesthetics may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to define the appropriate Bispectral Index (BIS) range and propofol effect-site concentration to maintain adequate anesthesia depth during total intravenous anesthesia (TIVA) when combined with either midazolam, dexmedetomidine, or esketamine in adults undergoing unilateral knee replacement. Participants are assigned to one of four regimens: propofol alone, or propofol with one of the three adjuvants, with a stepwise reduction of propofol near the end of surgery to assess recovery quality and postoperative pain. Outcomes focus on anesthesia depth control, recovery quality, and pain after surgery. The trial will be conducted at China-Japan Friendship Hospital in Beijing, with ASA I-II adults aged 18-65.

Why it matters

Potential benefit: If successful, it could help tailor anesthesia depth and drug combinations to improve recovery and pain control after knee replacement.

How similar studies have gone: Prior research has explored BIS guidance and adjuvant use in TIVA, but this specific combination with midazolam, dexmedetomidine, or esketamine for knee replacement is less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 65 years
* American Society of Anesthesiologists (ASA) physical status I or II
* Body Mass Index (BMI) 18 to 30 kg/m²
* Scheduled for elective unilateral total knee replacement surgery
* Willing to participate in the study and signed informed consent form, and able to comply with the intervention and assessment procedures

Exclusion Criteria:

* History of neurological disorders
* Cognitive dysfunction assessed by the Mini-Cog scale
* History of antipsychotic or sedative medication use in the past 4 weeks
* Poorly controlled or untreated hypertension
* Sinus bradycardia, cardiac conduction block, or severe heart failure
* Acute angle-closure glaucoma
* Allergic to intravenous anesthetics
* Hearing impairment, could not cooperate in intervention and evaluation
* Contraindications to tourniquet use on the upper arm

Where it's running

  • China-Japan Friendship Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.